ICH M10 draft [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2019-03-13 18:06 (767 d 04:06 ago) – Posting: # 20023
Views: 3,466

Dear all,

"New or Alternative Technologies" an interesting part in the newly issued draft of BIOANALYTICAL METHOD VALIDATION, ICH M10 which Endorsed on 26 February 2019.

- When a new or alternative technology is used as the sole bioanalytical technology from the onset of drug development, cross-validation with an existing technology is not required.
Cross-validation but required when using two different bioanalytical technologies for the development of a drug.

on the other hand, The use of two methods or technologies within a
comparative BA/BE study is strongly discouraged:. (i.e not applicable at all also with cross-validation).:confused::confused:
Why ??

Best regards,

Edit: Post moved. [Helmut]


Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,508 registered users;
online 10 (0 registered, 10 guests [including 3 identified bots]).
Forum time: Sunday 23:13 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz